← All trials
NCT05451498
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 9, 2022
- Primary completion
- May 5, 2022
- Completion date
- May 5, 2022
- First posted
- Jul 11, 2022
- Last posted
- Jul 12, 2022
- Enrollment
- 47
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of ColoradoLead sponsor
- Western Michigan UniversityCollaborator
- Western Michigan UniversityStudy director
- Mayo ClinicCollaborator
- Mayo ClinicStudy director
- University of ColoradoOverall official - principal investigator
- University of ColoradoReponsible party - principal investigator
- Lindenwood UniversityCollaborator
- Lindenwood UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.